Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion type Assertion NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_head.
- NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion description "[The capacity of N-SCLC cells to reactivate pRSV-CAT plasmid damaged with cisplatin and transfected into cells was higher in N-SCLC cells than in SCLC cells originating from patients who were untreated previously (P < 0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_provenance.
- NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion evidence source_evidence_literature NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_provenance.
- NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion SIO_000772 7585500 NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_provenance.
- NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion wasDerivedFrom befree-2016 NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_provenance.
- NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_assertion wasGeneratedBy ECO_0000203 NP1313755.RAbH9m_RjHoDlXjlXXMDSmfs3rul4TYCkTFozLcg4MGBo130_provenance.